Barclays Boosts Tenet Healthcare (NYSE:THC) Price Target to $171.00
Tenet Healthcare (NYSE:THC – Free Report) had its target price increased by Barclays from $156.00 to $171.00 in a report published on Monday morning, Benzinga reports. They currently have an overweight rating on the stock. THC has been the subject of a number of other reports. Robert W. Baird began coverage on Tenet Healthcare in […]
More Stories
Trump Calls for Temporary 10 Percent Cap on Credit Card Interest Rates
By Aldgra Fredly President Donald Trump said on Jan. 9 that he would call for a one-year cap on credit...
Trump Declares National Emergency to Shield Venezuelan Oil Revenues Held in US Custody
By Tom Ozimek President Donald Trump signed an executive order on Jan. 9 declaring a national emergency to block courts...
Operation Salvo Leads to Arrest of 54 Individuals in New York City: DHS
By Naveen Athrappully Authorities have arrested 54 individuals in New York under Operation Salvo, an immigrant enforcement operation that was...
DHS Launches Fraud Investigation Into Minnesota Refugee Program
By Savannah Hulsey Pointer The U.S. Citizenship and Immigration Services (USCIS) has launched an investigation in Minnesota, joining other federal...
Greenland Should Talk to US Without Denmark, Opposition Leader Says
By Rachel Roberts Greenland should hold talks with the United States government without Denmark being present, a Greenlandic opposition leader...
Musk’s xAI Plans $20 Billion Mississippi Data Center in Largest Investment in State History
By Evgenia Filimianova Elon Musk’s artificial intelligence startup xAI plans to invest more than $20 billion to build a large...